Q4 2023 Holdings
Filed 2024-02-15 | 46 holdings | $418.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $54.4M | 3,004,199 | 13.0% |
| Robinhood Mkts Inc(HOOD) | COM CL A | 770700102 | $54.0M | 4,237,409 | 12.9% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $34.8M | 3,419,842 | 8.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $32.4M | 1,332,302 | 7.7% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $31.5M | 1,198,270 | 7.5% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $30.2M | 2,045,070 | 7.2% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $22.8M | 3,122,499 | 5.4% |
| Acelyrin Inc | COM | 00445A100 | $17.1M | 2,292,990 | 4.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $15.5M | 3,414,468 | 3.7% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $14.0M | 352,633 | 3.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $12.6M | 263,238 | 3.0% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $11.4M | 1,234,760 | 2.7% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $8.5M | 1,493,252 | 2.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $8.1M | 140,260 | 1.9% |
| E2open Parent Holdings Inc(ETWOGBP) | COM CL A | 29788T103 | $7.2M | 1,650,943 | 1.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $6.6M | 71,888 | 1.6% |
| Toast Inc(TOST) | CL A | 888787108 | $6.0M | 5,890,274 | 1.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.4M | 1,270,027 | 1.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.9M | 568,379 | 1.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $4.4M | 2,829,712 | 1.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.9M | 65,000 | 0.9% |
| Ikena Oncology Inc | COM | 45175G108 | $3.8M | 1,953,616 | 0.9% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $3.3M | 340,000 | 0.8% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $3.2M | 1,055,882 | 0.8% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.8M | 864,822 | 0.7% |
| Dell Technologies Inc(DELL) | SHS | 24703L202 | $2.7M | 35,091 | 0.6% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $2.6M | 1,599,660 | 0.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.5M | 60,000 | 0.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $2.0M | 695,000 | 0.5% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $1.9M | 355,377 | 0.5% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $1.2M | 733,568 | 0.3% |
| Gohealth Inc(GOCO) | COM CL A | 38046W204 | $1.1M | 83,264 | 0.3% |
| Braze Inc(BRZE) | SHS | 10576N102 | $941.8K | 17,726 | 0.2% |
| Blend Labs Inc(BLND) | CL A | 09352U108 | $922.1K | 361,587 | 0.2% |
| Rallybio Corp | COM | 75120L100 | $837.1K | 350,240 | 0.2% |
| Desktop Metal Inc | COM CL A | 25058X105 | $563.3K | 750,000 | 0.1% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L206 | $552.0K | 86,654 | 0.1% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $403.8K | 475,077 | 0.1% |
| Uber Technologies Inc(UBER) | COM | 90353T100 | $380.9K | 6,187 | 0.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $295.6K | 10,013 | 0.1% |
| Fathom Digital MFG Corp | CL A COM | 31189Y103 | $222.9K | 50,000 | 0.1% |
| Precision Biosciences Inc | COM | 74019P108 | $221.4K | 606,629 | 0.1% |
| Alpha Partners Tech Mergr Co | *W EXP 03/31/202 | G63290103 | $0 | 666,666 | 0.0% |